Indonesia’s state railway KAI reported a 200% jump in disabled passengers using a 20% fare reduction in the first half of 2026, surpassing the full-year figure for 2025. The scheme, launched in September 2023, now reaches 2,953 beneficiaries, up from 983 a year earlier. KAI credits better awareness and station accessibility upgrades, including wheelchair-friendly toilets and guidance paths, as it positions the railway as a social connector for work, health, and family. That measurable expansion offers a counterpoint to more contentious healthcare and social security reforms unfolding elsewhere.

In Iran, pharmaceutical shortages are fuelling an illicit online trade, as pharmacists warn that life-saving drugs absent from chemist shops proliferate on social media and digital platforms at many times the official price. Industry figures say insurance arrears have stretched to six to seven months, squeezing liquidity, while US sanctions complicate imports of active ingredients – even though over 97% of finished drugs are manufactured domestically. Scarce items include cancer drug methotrexate, certain insulins, psychiatric medications, and blood products for haemophiliacs. Pharmacy owner Rasoul Nazarifard alleges electronic prescription systems, intended to improve efficiency, are being exploited to issue fake scripts, diverting subsidised drugs to the black market.

In the United States, a flurry of state and federal measures seeks to recalibrate support for the vulnerable, but with stricter gatekeeping. Florida’s HB 697, in effect from July 2026, strengthens pharmacies’ ability to appeal low reimbursements from pharmacy benefit managers and bars differential treatment of outlets, a response to claims that independent drugstores are being squeezed. The Social Security Administration announced operational improvements to the Supplemental Security Income (SSI) programme, such as automated financial checks and streamlined call handling, aiming to reduce overpayments and processing delays for elderly and disabled recipients. California’s SB 171, meanwhile, tightens eligibility for the Subsequent Injuries Benefits Trust Fund, requiring claimants to prove a prior disability demonstrably reduced earnings or work capacity before a new workplace injury, rather than merely documenting a pre-existing condition.

Argentina is reviving a debate over drug deregulation after a draft bill proposed allowing over-the-counter medicines to be sold in supermarkets, kiosks, and petrol stations. Pharmacist bodies, which successfully blocked a similar presidential decree in 2023, argue that even common painkillers like paracetamol carry risks of liver damage if misused and that removing the pharmacist cuts off vital counselling and pharmacovigilance. The bill also contemplates letting one technical director oversee multiple pharmacies and allowing wholesalers to dispense directly to the public. Provincial laws in Buenos Aires would limit the national reform’s reach, but the capital remains exposed.

Across disparate geographies, 2026 is a year of adjustment: Indonesia’s targeted fare cuts for disabled travellers show rapid uptake; Iran’s regulatory failures are deepening a two-tier medicine market; and in the Americas, lawmakers are balancing fiscal prudence with access. The next milestone to watch is the legislative progress of Argentina’s pharmaceutical bill, which will test how far Latin America’s third-largest economy is willing to go in dismantling its traditional pharmacy model.